✦ LIBER ✦

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

✍ Scribed by Joline S. W. Lind; Martijn R. Meijerink; Anne-Marie C. Dingemans; Cornelis van Kuijk; Michel C. Öllers; Dirk de Ruysscher; Pieter E. Postmus; Egbert F. Smit

Book ID: 113032656
Publisher: Springer
Year: 2010
Tongue: English
Weight: 308 KB
Volume: 20
Category: Article
ISSN: 0938-7994
DOI: 10.1007/s00330-010-1869-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Randomized Phase II Study of Sorafenib

A Randomized Phase II Study of Sorafenib/Gemcitabine or Sorafenib/Erlotinib for Advanced Non–Small-Cell Lung Cancer in Elderly Patients or Patients with a Performance Status of 2: Treatment Rationale and Protocol Dynamics

✍ Cesare Gridelli; Antonio Rossi; Floriana Mongillo; Maria Bareschino; Paolo Maion 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 108 KB

Usefulness of dynamic contrast enhanced

Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapy

✍ Lazanyi, Kornelia Szluha; Abramyuk, Andrij; Wolf, Gunter; Tokalov, Sergey; Zöphe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 456 KB

Dynamic contrast-enhanced CT to assess m

Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy

✍ Sung Ho Hwang, Mi Ri Yoo, Chul Hwan Park, Tae Joo Jeon, Sang Jin Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 438 KB

Dynamic-Contrast Enhanced MR and Volume

Dynamic-Contrast Enhanced MR and Volume Regression Rate as a Preoperative Predictive Assay in Patients With Non-Small Cell Lung Cancer

✍ Grecula, J.C.; Elias, S.; Thelen, K.; Knopp, M.; Otterson, G.; Ross, P.; Kassis, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 54 KB

PCN58 A COST UTILITY ANALYSIS OF ERLOTIN

PCN58 A COST UTILITY ANALYSIS OF ERLOTINIB IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)

✍ PA Bradbury; R Jang; P Isogai; R Ng; N Mittmann; W Evans; FA Shepherd; NB Leighl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

P84 Response monitoring with positron em

P84 Response monitoring with positron emission tomography (PET) in patients with advanced non-small-cell lung cancer (NSCLC) treated with bevacizumab and erlotinib: a phase II study

✍ A. de Langen; O. Hoekstra; A. Dingemans; H. Groen; V. van den Boogaart; J. Pruij 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB